GO
Loading...

Big pharma's prescription for profits

Tuesday, 30 Jul 2013 | 7:52 AM ET

Barbara Ryan, FTI Consulting, breaks down the second quarter numbers on Pfizer and Merck and provides an outlook on which companies have the best drugs in the pipeline.